Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab-Reference-Cited by-同舟云学术

Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

Published:2020-07-27 Issue:7 Volume:15 Page:e0235449
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kemmerer C. L.,Pernpeintner V.,Ruschil C.,Abdelhak A.,Scholl M.,Ziemann U.,Krumbholz M.,Hemmer B.,Kowarik M. C.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis;SL Hauser;N Engl J Med,2017

2. Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients;N Claes;J Immunol,2016

3. B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis;A Schwarz;Neurol Neuroimmunol Neuroinflamm,2017

4. Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients;J Habib;J Mult Scler,2015

5. B cells undergo unique compartmentalized redistribution in multiple sclerosis;J Haas;J Autoimmun,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications;European Journal of Medical Research;2024-06-25

2. Peripheral memory B cells in multiple sclerosis vs. double negative B cells in neuromyelitis optica spectrum disorder: disease driving B cell subsets during CNS inflammation;Frontiers in Cellular Neuroscience;2024-02-07

3. Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review;Current Pharmaceutical Design;2024-02

4. Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation;International Journal of Molecular Sciences;2024-01-23

5. Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets;Annals of Clinical and Translational Neurology;2024-01-10